Kinesiophobia in Stroke Patients and Affecting Factors

Last updated: September 8, 2022
Sponsor: Inonu University
Overall Status: Completed

Phase

N/A

Condition

Stroke

Cerebral Ischemia

Treatment

N/A

Clinical Study ID

NCT05538468
2019/3-22
  • Ages 25-70
  • All Genders

Study Summary

It was aimed to determine the presence of kinesiophobia that will affect the treatment in stroke patients and to investigate the relationship between these factors and kinesiophobia by examining factors such as postural control, depression, pain, and affected side that may cause kinesiophobia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • individuals who were diagnosed with hemiplegia or hemiparesis after SVO,
  • at least 6 months after SVO,
  • who were Level 2 and above according to the Functional Ambulation Classification,
  • who wanted to participate in the study voluntarily

Exclusion

Exclusion Criteria:

  • Anyone with a major neurological or rheumatological pathology (polyneuropathy,parkinson's, multiple sclerosis, rheumatoid arthritis, etc.)
  • Affecting the musculoskeletal system other than stroke
  • Who does not allow mental evaluation, cannot fill in the scales,
  • is illiterate, has aphasia, has a history of falling,
  • have any cardiac problems,
  • amputation in the lower extremities,
  • those with active malignancy and related chemo/radiotherapy,
  • the presence of accompanying lower motor neuron or peripheral nerve lesion,
  • any musculoskeletal problem and related pain (lumbar disc herniation, meniscus, etc.),
  • ındividuals with shoulder subluxation, shoulder-hand syndrome
  • those who refused to participate in the study

Study Design

Total Participants: 30
Study Start date:
February 10, 2019
Estimated Completion Date:
July 30, 2019

Study Description

Objective: This study was planned to investigate the relationship between depression, postural control, pain, affected side and kinesiophobia in stroke patients. Material and Method: Thirty patients aged between 25-70 years who had a stroke at the earliest 6 months and who Functional Ambulation Scale were level 2 and above according to the were included in the study. Patients were selected by random sampling method from the relevant population. Demographic data were obtained from all subjects who met the inclusion criteria. Patients were evaluated Kinesiophobia scores (Tampa Kinesiophobia Scale (TKÖ) and VAS-Kinesiophobia Assessment), depression severity (Beck Depression Inventory), postural control loss (PASS) and pain severity (VAS).

Connect with a study center

  • Inonu University

    Malatya,
    Turkey

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.